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We encountered a middle-aged afebrile immunocompetent woman with a slight cough. Positron
emission tomography (PET)/computed tomography (CT) revealed a broad left upper-lobe consolidation
without cavity lesions, small nodules, or bronchiectasis showing a positive ﬂuorodeoxyglucose (FDG)
uptake with a maximum standardized uptake value (SUVmax) of 26.9. Percutaneous needle lung biopsy
specimens showed caseous granulomas without atypical cells and Mycobacterium avium was cultured
from left pleural effusion, which developed after the biopsy. The consolidation signiﬁcantly decreased
following combination chemotherapy for approximately 2 years. Clinicians should remember that pul-
monary M. avium infection could result in a large consolidation without other typical radiological
ﬁndings.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Nontuberculous mycobacteria (NTM), especially Mycobacterium
(M.) avium complex (MAC), are being recognized with increasing
frequency as clinical pathogens of chronic lung disease in immu-
nocompetent patients [1,2]. The common ﬁndings of immunocom-
petent patients with NTM infection in chest computed tomography
(CT) are cavity lesions, endobronchial spread or randomly distrib-
uted small nodules with bronchiectasis, and consolidation [1e4].
The maximum standardized uptake values (SUVmax) of ﬂuo-
rodeoxyglucose (FDG) in positron emission tomography (PET) were
approximately 5e10 in the lesions of NTM infection [5,6].al Medicine, Shinshu Univer-
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Ltd. This is an open access article uWe herein report a case of pulmonary M. avium infection in an
immunocompetent woman with a non-disseminated broad
consolidation on chest CT and a high FDG uptake (SUVmax: 26.9) in
this consolidation on PET/CT.2. Case presentation
A 41-year-old Korean woman complained of a slight cough
without dyspnea or a fever. She was referred to our department by
her primary care physician. She was affected by tuberculosis when
she was 34 years of age in Korea and treated with unspeciﬁed
chemotherapy; no signs of relapses occurred until 41 years of age.
The precise data regarding her past clinical history in Korea were
unavailable. Her hearing ability was lost completely due to un-
known reasons. She had no history of diabetes mellitus or other
immunosuppressive diseases. Physical examinations at the initial
visit showed a height of 162.0 cm, body weight of 58.0 kg, arterial
blood pressure of 102/58 mmHg, pulse rate of 74/min, and body
temperature of 36.5 C. The breath sounds were decreased in the
left lung. No lymphadenopathy was found. Her laboratorynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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within the normal range and C-reactive protein (CRP) level was
increased to 2.91 mg/dL. The carcinoembryonic antigen (CEA)
value was normal, however, the soluble interleukin-2 receptor
(sIL-2R) value was increased to 1094 U/mL. The blood glucose level
was normal and HIV antibody was negative. The serum immuno-
globulin levels were normal. Both CD4þ and CD8þ lymphocyte
counts were in the normal ranges. An interferon-gamma release
assay (Cellestis Company, QuantiFERON® TB Gold) was negative.
The antigens for urine Streptococcus pneumoniae and Legionella
pneumophila were negative. The bacterial culture, acid-fast bacilli
smear and culture, and polymerase chain reaction (PCR) tests for
Mycobacterium tuberculosis, M. avium, and Mycobacterium intra-
cellulare of the sputumwere all negative. A chest X-ray and CT scan
showed a broad consolidation with an angiogram sign throughout
the upper-lobe of left lung, however, other imaging ﬁndings such
as cavity lesions, small nodules, and bronchiectasis were not
observed (Fig. 1AeC). Lymph nodes around the arch of the aorta
and under the carina of the trachea were slightly enlarged. PET/CT
showed a high SUVmax of 26.9 on the consolidation shadow
(Fig. 1D). Transbronchial aspiration cytology (TBAC) could not
obtain adequate specimens from the consolidation due to stenosis
of the left upper lobe bronchus. The cytodiagnosis, common bac-
terium culture, acid-fast bacilli smear and the PCR tests for
M. tuberculosis, M. avium, and M. intracellulare of the lavage ﬂuid
were all negative. Furthermore, the acid-fast bacilli culture of the
lavage ﬂuid was negative. Thus, a CT-guided percutaneous needle
lung biopsy was performed and the biopsy specimens showed
caseous granulomas without atypical cells by hematoxylin and
eosin (H&E) staining (Fig. 2), but no bacteria by Kinyoun staining.
The bacterial culture, acid-fast bacilli smear, acid-fast bacilli cul-
ture and PCR tests for M. tuberculosis, M. avium, and
M. intracellulare of the biopsy specimens were negative. The
consolidation of the left lung enlarged and left pleural effusion
developed one week following the lung biopsy (Fig. 1E). Thus, we
performed a diagnostic puncture in the left thorax. The pleural
effusion was lymphocyte predominant and serological tests
showed a total protein (TP) concentration of 5.0 g/dL, albumin of
2.5 g/dL, lactate dehydrogenase (LD) of 223 IU/L, glucose of 95 mg/
dL, immunoglobulin G (IgG) of 1216 mg/dL, and adenosine
deaminase (ADA) of 84.3 U/L. Effusion specimens were negative for
antinuclear antibody (ANA) and rheumatoid factor (RF). The acid-
fast bacilli smear and PCR tests forM. tuberculosis,M. avium, andM.
intracellulare of the effusionwere all negative Finally,M. aviumwasTable 1
The patient’s laboratory data at the initial visit.
Hematology Blood Chemistry
WBC 5660 /mL TP 6.
Neutrophil 63.7 % ALB 3.
Monocyte 7.6 % UN 10
Eosinophil 4.4 % Cre 0.
Basophil 0.4 % AST 13
Lymphocyte 23.9 % ALT 9
CD4 29 % g-GTP 15
CD8 44 % T-bil 0.
RBC 479  104 /mL ALP 19
Hb 12.3 LDH 16
Plt 38.7 /mL Na 13
K 4.
Tumor marker Cl 98
CEA (<3.4) 1.6 ng/mL 88
CA19-9 (<37.0) 153.3 U/mL
sIL-2R (<421) 1094 U/mL Glu 88
ESR
1h 40 mm
2h 76 mmcultured from the left pleural effusion and we diagnosed the pa-
tient with M. avium infection.
Because ethambutol (EB) was thought to be unsuitable due to
her complete hearing loss, combination chemotherapy with
rifampicin (RFP) 450 mg, clarithromycin (CAM) 800 mg, and levo-
ﬂoxacin (LVFX) 500 mg were administered. The chest image
signiﬁcantly improved after two years of this chemotherapy
(Fig. 1F).
3. Discussion
NTM may cause both asymptomatic infection and symptomatic
disease in humans [2]. It has been reported that the incidence of a
fever was approximately 10e20% in NTM patients without HIV
infection [7e9] and 74% in NTM patients with HIV infection [9].
Thus, there is a danger of unintentionally overlooking this infec-
tious disease, especially in afebrile immunocompetent patients
with mild symptoms like our case.
Several investigators have reported the CT ﬁndings of NTM pa-
tients without underlying lung disease and micronodules
(95e100%), bronchiectasis (65e94%), cavity formation (13e43%),
air space consolidation (22e62%), and pleural thickening (17e52%)
were frequently observed in these communications [8]. A study of
59 Japanese patients withM. avium complex infection reported that
the rates of small nodules, nodules, bronchiectasis, atelectasis,
cavity formation, consolidation, and pleural effusion were 100%,
81.3%, 76.2%, 59.3%, 37.3%, 22.0%, and 8.5%, respectively, on chest CT
[8]. Interestingly, all of the patients with consolidation showed
other common CT ﬁndings of NTM infection in this study [8].
Although consolidation is one of the common CT ﬁndings in NTM
infection, we believe that it is rare for patients with M. avium
infection to present with common CT ﬁndings of NTM infection
other than the consolidation of the left lung.
The broad consolidation with a positive angiogram sign on
chest CT suggested that the pulmonary structures of the bronchus
and blood vessels might not be destroyed, which might be
observed in pneumonia and malignant neoplasms such as malig-
nant lymphoma and invasive mucinous adenocarcinoma [10].
Because the present case clinically showed fewer respiratory
symptoms without a fever, her large consolidation on chest CT was
suspected to be malignant neoplasms, such as malignant lym-
phoma, at the beginning visit. We speculated that acid-fast bacillus
infections could show a FDG accumulation on PET/CT, however, we
had not previously experienced such a high SUVmax in aSerological tests
8 g/dL CRP 2.91 mg/dL
2 g/dL IgA 207 mg/dl
mg/dL IgM 136 mg/dl
57 mg/dL IgG 1422 mg/dl
IU/L IgD 0.8 mg/dl
IU/L IgE 35 IU/ml
IU/L
47 mg/dL HIV antibody e
IU/L
0 IU/L Urinalysis
6 mEq/L PH 7.0
3 mEq/L SG 1.010
mEq/L Protein e
Glucose e
Occult blood e
mg/dL Bacteria e
Urine testing for bacterial antigens
S. pneumoniae e
L. pneumophila e
Fig. 1. A chest X-ray (A) and CT (B, C) scan at the initial visit revealed broad consolidation with a positive angiogram sign (arrow) throughout the upper-lobe of the left lung. PET/CT
showed a high SUVmax of 26.9 on the consolidation of the left lung (D). A subsequent chest X-ray one week after the percutaneous lung biopsy showed the consolidation getting
broader and the development of left pleural effusion (E). A chest X-ray taken two years after chemotherapy revealed a signiﬁcant improvement in the consolidation and pleural
effusion (F).
Fig. 2. Percutaneous lung biopsy specimens showed caseous granulomas without
atypical cells on hematoxylin and eosin (H&E) staining. Scale bar ¼ 250 mm.
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the highest value observed on chest CT of the lesions in NTM
infection.Although acid-fast bacillus infections could be suspected ac-
cording to the evidence of caseous granulomas from percutaneous
biopsies specimens, acid-fast bacilli were not detected in the smear
of the biopsy specimen or PCR tests. Although tuberculous pleural
effusion may occur in up to 30% of patients with tuberculosis [11],
the incidence of pleural effusion in NTM infection is relatively low
[8]. Combination chemotherapy for tuberculosis in this patient was
administered primarily regarding her history of tuberculosis and
high levels of ADA in the pleural effusion, which were suitable
markers in the diagnosis of tuberculous pleuritis [11e14].M. avium
was cultured from the gastric ﬂuid, which is not listed in the diag-
nostic criteria of NTM infection approved by the American Thoracic
Society (ATS)/Infectious Diseases Society of America (IDSA) [1], and
we eventually observed M. avium in the pleural effusion culture as
well. The present casewas diagnosedwith pulmonary infection and
pleurisy due toM. avium infection according to the strong laboratory
evidence of M. avium culture. A previous report showed that a pa-
tientwithM. avium pleuritis had a normal level of ADA in the pleural
effusion [15]. Conversely, several caseswithNTMinfections revealed
high ADA concentrations in the pleural effusion [16], such as in our
case. Thus, our case reafﬁrms that ADA concentrations in the pleural
effusion of patients with NTM infections could be high.
4. Conclusion
We presented an immunocompetent afebrile patient with
M. avium infection showing a non-disseminated broad consolida-
tion without other typical sings of NTM infection in chest CT im-
ages. Furthermore, M. avium infection may reveal a large
consolidation with high FDG uptake in chest PET/CT images.
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